Galapagos Scipher Medicine, Galapagos Sign IBD Drug Development Deal The companies will jointly validate novel drug targets identified by Scipher's molecular interaction network platform for patients with inflammatory bowel disease. Charles River Laboratories Buying BioFocus, Argenta from Galapagos for up to $187M NEW YORK (GenomeWeb News) – Charles River Laboratories has signed a definitive agreement to purchase Galapagos' BioFocus and Argenta service division operations for a total consideration of €134 million ($187 million), the companies announced today. In Brief This Week: AB Sciex; Enzo Biochem; Sigma-Aldrich; Precision BioSciences, Cellectis; Quidel; Galapagos, AstraZeneca; Cartagenia Galapagos' BioFocus Business Extends Contract with Amgen The extension calls for the use of BioFocus' target discovery platform to deliver novel targets in support of Amgen's therapeutic programs. BioFocus Joins Argenta, Genentech Research Alliance BioFocus will provide Genentech with integrated medicinal chemistry, in vitro biology, and ADME services. Jul 12, 2010 NIH Extends Agreement with Galapagos for MLSMR Jun 28, 2010 Galapagos Raises $430K through Warrants Exercise Feb 2, 2010 Galapagos Acquires Drug Discovery Services Business Jan 20, 2010 EMBL Launches Genomic-Based Drug Data Resource Oct 16, 2009 Galapagos Raises $27.1M in Share Placement Oct 14, 2009 Galapagos Expands Merck Drug Target Pact Jul 22, 2009 StarDrop Developers Acquire Software from BioFocus DPI, Launch New Firm Premium Mar 6, 2009 News Scan : Mar 6, 2009 Premium Mar 6, 2009 BioFocus' 2008 Revenues Increase 16 Percent Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.